Application of genomics, proteomics and metabolomics in drug discovery, development and clinic. (March 2013)
- Record Type:
- Journal Article
- Title:
- Application of genomics, proteomics and metabolomics in drug discovery, development and clinic. (March 2013)
- Main Title:
- Application of genomics, proteomics and metabolomics in drug discovery, development and clinic
- Authors:
- Russell, Craig
Rahman, Ayesha
Mohammed, Afzal R - Abstract:
- Genomics, proteomics and metabolomics are three areas that are routinely applied throughout the drug-development process as well as after a product enters the market. This review discusses all three 'omics, reporting on the key applications, techniques, recent advances and expectations of each. Genomics, mainly through the use of novel and next-generation sequencing techniques, has advanced areas of drug discovery and development through the comparative assessment of normal and diseased-state tissues, transcription and/or expression profiling, side-effect profiling, pharmacogenomics and the identification of biomarkers. Proteomics, through techniques including isotope coded affinity tags, stable isotopic labeling by amino acids in cell culture, isobaric tags for relative and absolute quantification, multidirectional protein identification technology, activity-based probes, protein/peptide arrays, phage displays and two-hybrid systems is utilized in multiple areas through the drug development pipeline including target and lead identification, compound optimization, throughout the clinical trials process and after market analysis. Metabolomics, although the most recent and least developed of the three 'omics considered in this review, provides a significant contribution to drug development through systems biology approaches. Already implemented to some degree in the drug-discovery industry and used in applications spanning target identification through to toxicologicalGenomics, proteomics and metabolomics are three areas that are routinely applied throughout the drug-development process as well as after a product enters the market. This review discusses all three 'omics, reporting on the key applications, techniques, recent advances and expectations of each. Genomics, mainly through the use of novel and next-generation sequencing techniques, has advanced areas of drug discovery and development through the comparative assessment of normal and diseased-state tissues, transcription and/or expression profiling, side-effect profiling, pharmacogenomics and the identification of biomarkers. Proteomics, through techniques including isotope coded affinity tags, stable isotopic labeling by amino acids in cell culture, isobaric tags for relative and absolute quantification, multidirectional protein identification technology, activity-based probes, protein/peptide arrays, phage displays and two-hybrid systems is utilized in multiple areas through the drug development pipeline including target and lead identification, compound optimization, throughout the clinical trials process and after market analysis. Metabolomics, although the most recent and least developed of the three 'omics considered in this review, provides a significant contribution to drug development through systems biology approaches. Already implemented to some degree in the drug-discovery industry and used in applications spanning target identification through to toxicological analysis, metabolic network understanding is essential in generating future discoveries. … (more)
- Is Part Of:
- Therapeutic delivery. Volume 4:Number 3(2013)
- Journal:
- Therapeutic delivery
- Issue:
- Volume 4:Number 3(2013)
- Issue Display:
- Volume 4, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 4
- Issue:
- 3
- Issue Sort Value:
- 2013-0004-0003-0000
- Page Start:
- 395
- Page End:
- 413
- Publication Date:
- 2013-03
- Subjects:
- Drug delivery systems -- Periodicals
Therapeutics -- Periodicals
615.6 - Journal URLs:
- http://www.future-science.com/loi/tde ↗
http://www.future-science.com/ ↗ - DOI:
- 10.4155/tde.13.4 ↗
- Languages:
- English
- ISSNs:
- 2041-5990
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16701.xml